Mary Anderson

Mary L. Anderson is a seasoned executive in the biopharmaceutical industry with extensive experience in business development and strategic planning. Currently, Mary L. Anderson serves as the Senior Vice President of Business Development at Iambic Therapeutics, a role held since November 2021. Previously, Mary L. Anderson was Vice President of Corporate Strategy, Business Development, and Alliance Management at Turning Point Therapeutics and held the position of Vice President, Head of Business Development and Alliance Management at Radius Health, Inc. Additionally, Mary L. Anderson has significant experience from roles at NovaMedica, Merck KGaA, MorphoSys, Agensys, and Bayer, with responsibilities spanning from managerial to executive levels in business development. Mary L. Anderson holds a Bachelor of Science in Biochemistry from California Polytechnic State University-San Luis Obispo and an MBA from Saint Mary's College of California.